Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database

Background: Recent short-term clinical trials in patients with Duchenne Muscular Dystrophy (DMD) have indicated greater disease variability in terms of progression than expected. In addition, as average life-expectancy increases, reliable data is required on clinical progression in the older DMD pop...

Descripción completa

Detalles Bibliográficos
Autores: Koeks, Zaïda, Bladen, Catherine L, Salgado, David, van Zwet, Erik, Pogoryelova, Oksana, McMacken, Grace, Monges, Soledad, Foncuberta, Maria E, Kekou, Kyriaki, Kosma, Konstantina, Dawkins, Hugh, Lamont, Leanne, Bellgard, Matthew I, Roy, Anna J, Chamova, Teodora, Guergueltcheva, Velina, Chan, Sophelia, Korngut, Lawrence, Campbell, Craig, Dai, Yi, Wang, Jen, Barišić, Nina, Brabec, Petr, Lähdetie, Jaana, Walter, Maggie C, Schreiber-Katz, Olivia, Karcagi, Veronika, Garami, Marta, Herczegfalvi, Agnes, Viswanathan, Venkatarman, Bayat, Farhad, Buccella, Filippo, Ferlini, Alessandra, Kimura, En, van den Bergen, Janneke C, Rodrigues, Miriam, Roxburgh, Richard, Lusakowska, Anna, Kostera-Pruszczyk, Anna, Santos, Rosário, Neagu, Elena, Artemieva, Svetlana, Rasic, Vedrana Milic, Vojinovic, Dina, Posada De la Paz, Manuel, Bloetzer, Clemens, Klein, Andrea, Díaz-Manera, Jordi, Gallardo, Eduard, Karaduman, A Ayşe, Oznur, Tunca, Topaloğlu, Haluk, El Sherif, Rasha, Stringer, Angela, Shatillo, Andriy V, Martin, Ann S, Peay, Holly L, Kirschner, Jan, Flanigan, Kevin M, Straub, Volker, Bushby, Kate, Béroud, Christophe, Verschuuren, Jan J, Lochmüller, Hanns
Tipo de recurso: artículo
Fecha de publicación:2017
País:España
Institución:Instituto de Salud Carlos III (ISCIII)
Repositorio:Repisalud
Idioma:inglés
OAI Identifier:oai:repisalud.isciii.es:20.500.12105/15573
Acceso en línea:http://hdl.handle.net/20.500.12105/15573
Access Level:acceso abierto
Palabra clave:Adolescent
Adrenal Cortex Hormones
Adult
Child
Child, Preschool
Cross-Sectional Studies
Databases as Topic
Humans
Infant
Infant, Newborn
Male
Muscular Dystrophy, Duchenne
Treatment Outcome
Young Adult
id ES_27dbcf0d07926cd2ad0e5ed05ee13e45
oai_identifier_str oai:repisalud.isciii.es:20.500.12105/15573
network_acronym_str ES
network_name_str España
repository_id_str
spelling Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global DatabaseKoeks, ZaïdaBladen, Catherine LSalgado, Davidvan Zwet, ErikPogoryelova, OksanaMcMacken, GraceMonges, SoledadFoncuberta, Maria EKekou, KyriakiKosma, KonstantinaDawkins, HughLamont, LeanneBellgard, Matthew IRoy, Anna JChamova, TeodoraGuergueltcheva, VelinaChan, SopheliaKorngut, LawrenceCampbell, CraigDai, YiWang, JenBarišić, NinaBrabec, PetrLähdetie, JaanaWalter, Maggie CSchreiber-Katz, OliviaKarcagi, VeronikaGarami, MartaHerczegfalvi, AgnesViswanathan, VenkatarmanBayat, FarhadBuccella, FilippoFerlini, AlessandraKimura, Envan den Bergen, Janneke CRodrigues, MiriamRoxburgh, RichardLusakowska, AnnaKostera-Pruszczyk, AnnaSantos, RosárioNeagu, ElenaArtemieva, SvetlanaRasic, Vedrana MilicVojinovic, DinaPosada De la Paz, ManuelBloetzer, ClemensKlein, AndreaDíaz-Manera, JordiGallardo, EduardKaraduman, A AyşeOznur, TuncaTopaloğlu, HalukEl Sherif, RashaStringer, AngelaShatillo, Andriy VMartin, Ann SPeay, Holly LKirschner, JanFlanigan, Kevin MStraub, VolkerBushby, KateBéroud, ChristopheVerschuuren, Jan JLochmüller, HannsAdolescentAdrenal Cortex HormonesAdultChildChild, PreschoolCross-Sectional StudiesDatabases as TopicHumansInfantInfant, NewbornMaleMuscular Dystrophy, DuchenneTreatment OutcomeYoung AdultBackground: Recent short-term clinical trials in patients with Duchenne Muscular Dystrophy (DMD) have indicated greater disease variability in terms of progression than expected. In addition, as average life-expectancy increases, reliable data is required on clinical progression in the older DMD population. Objective: To determine the effects of corticosteroids on major clinical outcomes of DMD in a large multinational cohort of genetically confirmed DMD patients. Methods: In this cross-sectional study we analysed clinical data from 5345 genetically confirmed DMD patients from 31 countries held within the TREAT-NMD global DMD database. For analysis patients were categorised by corticosteroid background and further stratified by age. Results: Loss of ambulation in non-steroid treated patients was 10 years and in corticosteroid treated patients 13 years old (p = 0.0001). Corticosteroid treated patients were less likely to need scoliosis surgery (p < 0.001) or ventilatory support (p < 0.001) and there was a mild cardioprotective effect of corticosteroids in the patient population aged 20 years and older (p = 0.0035). Patients with a single deletion of exon 45 showed an increased survival in contrast to other single exon deletions. Conclusions: This study provides data on clinical outcomes of DMD across many healthcare settings and including a sizeable cohort of older patients. Our data confirm the benefits of corticosteroid treatment on ambulation, need for scoliosis surgery, ventilation and, to a lesser extent, cardiomyopathy. This study underlines the importance of data collection via patient registries and the critical role of multi-centre collaboration in the rare disease field.IOS PressUnión Europea. Comisión Europea. 6 Programa MarcoUnión Europea. Comisión Europea. 7 Programa MarcoMedical Research Council (Reino Unido)20232023-03-0620172017-01-0120172017-01-01research articlehttp://purl.org/coar/resource_type/c_2df8fbb1VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/20.500.12105/15573reponame:Repisaludinstname:Instituto de Salud Carlos III (ISCIII)InglésengEuropean Commission http://dx.doi.org/10.13039/501100000780 Seventh Framework Programme 305444European Commission http://dx.doi.org/10.13039/501100000780 Seventh Framework Programme 305121EC FP6 20123307EC FP6 16104EC FP6 036825open accesshttp://purl.org/coar/access_right/c_abf2Attribution-NoDerivatives 4.0 Internacionalhttp://creativecommons.org/licenses/by-nd/4.0/info:eu-repo/semantics/openAccessoai:repisalud.isciii.es:20.500.12105/155732026-06-12T12:43:37Z
dc.title.none.fl_str_mv Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database
title Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database
spellingShingle Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database
Koeks, Zaïda
Adolescent
Adrenal Cortex Hormones
Adult
Child
Child, Preschool
Cross-Sectional Studies
Databases as Topic
Humans
Infant
Infant, Newborn
Male
Muscular Dystrophy, Duchenne
Treatment Outcome
Young Adult
title_short Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database
title_full Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database
title_fullStr Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database
title_full_unstemmed Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database
title_sort Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database
dc.creator.none.fl_str_mv Koeks, Zaïda
Bladen, Catherine L
Salgado, David
van Zwet, Erik
Pogoryelova, Oksana
McMacken, Grace
Monges, Soledad
Foncuberta, Maria E
Kekou, Kyriaki
Kosma, Konstantina
Dawkins, Hugh
Lamont, Leanne
Bellgard, Matthew I
Roy, Anna J
Chamova, Teodora
Guergueltcheva, Velina
Chan, Sophelia
Korngut, Lawrence
Campbell, Craig
Dai, Yi
Wang, Jen
Barišić, Nina
Brabec, Petr
Lähdetie, Jaana
Walter, Maggie C
Schreiber-Katz, Olivia
Karcagi, Veronika
Garami, Marta
Herczegfalvi, Agnes
Viswanathan, Venkatarman
Bayat, Farhad
Buccella, Filippo
Ferlini, Alessandra
Kimura, En
van den Bergen, Janneke C
Rodrigues, Miriam
Roxburgh, Richard
Lusakowska, Anna
Kostera-Pruszczyk, Anna
Santos, Rosário
Neagu, Elena
Artemieva, Svetlana
Rasic, Vedrana Milic
Vojinovic, Dina
Posada De la Paz, Manuel
Bloetzer, Clemens
Klein, Andrea
Díaz-Manera, Jordi
Gallardo, Eduard
Karaduman, A Ayşe
Oznur, Tunca
Topaloğlu, Haluk
El Sherif, Rasha
Stringer, Angela
Shatillo, Andriy V
Martin, Ann S
Peay, Holly L
Kirschner, Jan
Flanigan, Kevin M
Straub, Volker
Bushby, Kate
Béroud, Christophe
Verschuuren, Jan J
Lochmüller, Hanns
author Koeks, Zaïda
author_facet Koeks, Zaïda
Bladen, Catherine L
Salgado, David
van Zwet, Erik
Pogoryelova, Oksana
McMacken, Grace
Monges, Soledad
Foncuberta, Maria E
Kekou, Kyriaki
Kosma, Konstantina
Dawkins, Hugh
Lamont, Leanne
Bellgard, Matthew I
Roy, Anna J
Chamova, Teodora
Guergueltcheva, Velina
Chan, Sophelia
Korngut, Lawrence
Campbell, Craig
Dai, Yi
Wang, Jen
Barišić, Nina
Brabec, Petr
Lähdetie, Jaana
Walter, Maggie C
Schreiber-Katz, Olivia
Karcagi, Veronika
Garami, Marta
Herczegfalvi, Agnes
Viswanathan, Venkatarman
Bayat, Farhad
Buccella, Filippo
Ferlini, Alessandra
Kimura, En
van den Bergen, Janneke C
Rodrigues, Miriam
Roxburgh, Richard
Lusakowska, Anna
Kostera-Pruszczyk, Anna
Santos, Rosário
Neagu, Elena
Artemieva, Svetlana
Rasic, Vedrana Milic
Vojinovic, Dina
Posada De la Paz, Manuel
Bloetzer, Clemens
Klein, Andrea
Díaz-Manera, Jordi
Gallardo, Eduard
Karaduman, A Ayşe
Oznur, Tunca
Topaloğlu, Haluk
El Sherif, Rasha
Stringer, Angela
Shatillo, Andriy V
Martin, Ann S
Peay, Holly L
Kirschner, Jan
Flanigan, Kevin M
Straub, Volker
Bushby, Kate
Béroud, Christophe
Verschuuren, Jan J
Lochmüller, Hanns
author_role author
author2 Bladen, Catherine L
Salgado, David
van Zwet, Erik
Pogoryelova, Oksana
McMacken, Grace
Monges, Soledad
Foncuberta, Maria E
Kekou, Kyriaki
Kosma, Konstantina
Dawkins, Hugh
Lamont, Leanne
Bellgard, Matthew I
Roy, Anna J
Chamova, Teodora
Guergueltcheva, Velina
Chan, Sophelia
Korngut, Lawrence
Campbell, Craig
Dai, Yi
Wang, Jen
Barišić, Nina
Brabec, Petr
Lähdetie, Jaana
Walter, Maggie C
Schreiber-Katz, Olivia
Karcagi, Veronika
Garami, Marta
Herczegfalvi, Agnes
Viswanathan, Venkatarman
Bayat, Farhad
Buccella, Filippo
Ferlini, Alessandra
Kimura, En
van den Bergen, Janneke C
Rodrigues, Miriam
Roxburgh, Richard
Lusakowska, Anna
Kostera-Pruszczyk, Anna
Santos, Rosário
Neagu, Elena
Artemieva, Svetlana
Rasic, Vedrana Milic
Vojinovic, Dina
Posada De la Paz, Manuel
Bloetzer, Clemens
Klein, Andrea
Díaz-Manera, Jordi
Gallardo, Eduard
Karaduman, A Ayşe
Oznur, Tunca
Topaloğlu, Haluk
El Sherif, Rasha
Stringer, Angela
Shatillo, Andriy V
Martin, Ann S
Peay, Holly L
Kirschner, Jan
Flanigan, Kevin M
Straub, Volker
Bushby, Kate
Béroud, Christophe
Verschuuren, Jan J
Lochmüller, Hanns
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Unión Europea. Comisión Europea. 6 Programa Marco
Unión Europea. Comisión Europea. 7 Programa Marco
Medical Research Council (Reino Unido)

dc.subject.none.fl_str_mv Adolescent
Adrenal Cortex Hormones
Adult
Child
Child, Preschool
Cross-Sectional Studies
Databases as Topic
Humans
Infant
Infant, Newborn
Male
Muscular Dystrophy, Duchenne
Treatment Outcome
Young Adult
topic Adolescent
Adrenal Cortex Hormones
Adult
Child
Child, Preschool
Cross-Sectional Studies
Databases as Topic
Humans
Infant
Infant, Newborn
Male
Muscular Dystrophy, Duchenne
Treatment Outcome
Young Adult
description Background: Recent short-term clinical trials in patients with Duchenne Muscular Dystrophy (DMD) have indicated greater disease variability in terms of progression than expected. In addition, as average life-expectancy increases, reliable data is required on clinical progression in the older DMD population. Objective: To determine the effects of corticosteroids on major clinical outcomes of DMD in a large multinational cohort of genetically confirmed DMD patients. Methods: In this cross-sectional study we analysed clinical data from 5345 genetically confirmed DMD patients from 31 countries held within the TREAT-NMD global DMD database. For analysis patients were categorised by corticosteroid background and further stratified by age. Results: Loss of ambulation in non-steroid treated patients was 10 years and in corticosteroid treated patients 13 years old (p = 0.0001). Corticosteroid treated patients were less likely to need scoliosis surgery (p < 0.001) or ventilatory support (p < 0.001) and there was a mild cardioprotective effect of corticosteroids in the patient population aged 20 years and older (p = 0.0035). Patients with a single deletion of exon 45 showed an increased survival in contrast to other single exon deletions. Conclusions: This study provides data on clinical outcomes of DMD across many healthcare settings and including a sizeable cohort of older patients. Our data confirm the benefits of corticosteroid treatment on ambulation, need for scoliosis surgery, ventilation and, to a lesser extent, cardiomyopathy. This study underlines the importance of data collection via patient registries and the critical role of multi-centre collaboration in the rare disease field.
publishDate 2017
dc.date.none.fl_str_mv 2017
2017-01-01
2017
2017-01-01
2023
2023-03-06
dc.type.none.fl_str_mv research article
http://purl.org/coar/resource_type/c_2df8fbb1
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv http://hdl.handle.net/20.500.12105/15573
url http://hdl.handle.net/20.500.12105/15573
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.relation.none.fl_str_mv European Commission http://dx.doi.org/10.13039/501100000780 Seventh Framework Programme 305444
European Commission http://dx.doi.org/10.13039/501100000780 Seventh Framework Programme 305121
EC FP6 20123307
EC FP6 16104
EC FP6 036825
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution-NoDerivatives 4.0 Internacional
http://creativecommons.org/licenses/by-nd/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution-NoDerivatives 4.0 Internacional
http://creativecommons.org/licenses/by-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv IOS Press
publisher.none.fl_str_mv IOS Press
dc.source.none.fl_str_mv reponame:Repisalud
instname:Instituto de Salud Carlos III (ISCIII)
instname_str Instituto de Salud Carlos III (ISCIII)
reponame_str Repisalud
collection Repisalud
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869404912334405632
score 15,812429